Squarepoint
MRVI icon

Squarepoint’s Maravai LifeSciences MRVI Stock Holding History

Squarepoint’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
+20,440
New +$88.2K ﹤0.01% 4162
2025
Q2 		– Sell
-180,913
Closed -$400K – 4848
2025
Q1 		$400K Buy
+180,913
New +$715K ﹤0.01% 3496
2024
Q4 		– Sell
-71,959
Closed -$598K – 5339
2024
Q3 		$598K Sell
71,959
-283,631
-80% -$2.45M ﹤0.01% 2972
2024
Q2 		$2.55M Buy
355,590
+229,421
+182% +$1.98M ﹤0.01% 1864
2024
Q1 		$1.09M Sell
126,169
-183,851
-59% -$1.24M ﹤0.01% 2526
2023
Q4 		$2.03M Buy
+310,020
New +$2M ﹤0.01% 1983
2023
Q3 		– Sell
-265,700
Closed -$3.3M – 4075
2023
Q2 		$3.3M Buy
265,700
+98,399
+59% +$1.33M 0.01% 1334
2023
Q1 		$2.34M Buy
167,301
+119,467
+250% +$1.72M 0.01% 1328
2022
Q4 		$685K Buy
+47,834
New +$753K ﹤0.01% 2087
2022
Q2 		– Sell
-20,428
Closed -$720K – 3191
2022
Q1 		$720K Sell
20,428
-40,725
-67% -$1.37M ﹤0.01% 1791
2021
Q4 		$2.56M Buy
+61,153
New +$2.48M 0.01% 1112
2021
Q3 		– Sell
-186,062
Closed -$7.76M – 3233
2021
Q2 		$7.76M Buy
186,062
+34,062
+22% +$1.32M 0.03% 550
2021
Q1 		$5.42M Sell
152,000
-152,479
-50% -$5.05M 0.03% 592
2020
Q4 		$8.54M Buy
+304,479
New +$8.48M 0.06% 299

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Squarepoint's MRVI Position: Q2 2026 in Review

Squarepoint opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 20,440 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #4162 among its holdings. This is a return to the name: Squarepoint previously reported a position in MRVI as recently as Q1 2025.

Squarepoint first reported a position in MRVI in Q4 2020 and has held it in 14 quarters since. The position peaked at $8.54M in Q4 2020. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Squarepoint held 20,440 shares of Maravai LifeSciences worth $128K as of Q2 2026.
  • Maravai LifeSciences was a new Squarepoint position in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4162 holding.
  • Squarepoint first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 14 quarters since.
  • Squarepoint's Maravai LifeSciences position peaked at $8.54M in Q4 2020.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.